Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reducing myoclonus after etomidate

A W Doenicke1, M F Roizen, J Kugler

  • 1Institute for Anesthesiology, Ludwig-Maximilians University, Munich, Germany. ostwald@lrz-muenchen.de

Anesthesiology
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pop-up Langmuir probe diagnostic in the water cooled divertor of Wendelstein 7-X.

The Review of scientific instruments·2024
Same author

A prospective whole-mixture approach to assess risk of the food and chemical exposome.

Nature food·2023
Same author

Are German family practitioners and psychiatrists sufficiently trained to diagnose and treat patients with alcohol problems?

BMC family practice·2019
Same author

Genotyping of human neutrophil antigens 1, 3, 4 and 5 using a novel multiplex polymerase chain reaction.

Transfusion medicine (Oxford, England)·2019
Same author

Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparins.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018
Same author

[Patient satisfaction in ambulatory cataract surgery : Differences between outpatients in a special surgery or in a hospital].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2017
Same journal

The Time-out.

Anesthesiology·2026
Same journal

Evaluation of Post-block Hypersensitivity Using Quantitative Sensory Testing Before, During, and After Axillary Brachial Plexus Block Resolution in Healthy Volunteers.

Anesthesiology·2026
Same journal

The state of medical education research in Anesthesiology: Current landscape and future directions - An initiative of the Anesthesia Research Council.

Anesthesiology·2026
Same journal

Diagnostic Ultrasound-guided Focused Ultrasound-induced Noninvasive, Reversible Peripheral Nerve Blockade in an In Vivo Model of Acute Pain: A Proof-of-Concept Study.

Anesthesiology·2026
Same journal

S-Ketamine Reduces Risk of Postoperative Delirium: Comment.

Anesthesiology·2026
Same journal

Computed Tomography-Based Body Composition Assessment for Preoperative Cardiovascular Risk Prediction: A Prospective Cohort Study.

Anesthesiology·2026
See all related articles

Myoclonus after etomidate is dose-dependent and can be reduced with pretreatment. This muscle twitching is not associated with seizure-like activity on electroencephalogram (EEG) monitoring.

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Neurology

Background:

  • Myoclonus is a potential side effect of etomidate anesthesia.
  • The relationship between etomidate dosage and myoclonus requires further investigation.
  • Understanding etomidate-induced myoclonus is crucial for patient safety.

Purpose of the Study:

  • To determine if myoclonus following etomidate administration is dose-related.
  • To assess the efficacy of etomidate pretreatment in suppressing myoclonus.
  • To investigate the association between myoclonus and seizure-like activity on electroencephalogram (EEG).

Main Methods:

  • Three studies were conducted involving human participants.
  • Dose-ranging studies evaluated etomidate from 0.025 to 0.300 mg/kg.

Related Experiment Videos

  • Crossover and parallel-group designs assessed pretreatment effects and EEG activity.

    • Main Results:

    • Myoclonus incidence increased with higher etomidate doses (P < 0.01).
    • Pretreatment with low-dose etomidate significantly reduced myoclonus compared to placebo (P < 0.05).
    • No seizure-like EEG activity was observed during myoclonic episodes.

    Conclusions:

    • Etomidate-induced myoclonus is directly related to the administered dose.
    • Pretreatment with etomidate effectively mitigates the occurrence and severity of myoclonus.
    • Myoclonus associated with etomidate does not indicate epileptiform EEG changes.